Group One Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-237,835
Closed -$371K 8568
2022
Q2
$428K Sell
237,835
-16,097
-6% -$23.7K ﹤0.01% 3579
2022
Q1
$513K Buy
253,932
+4,582
+2% +$9K ﹤0.01% 3786
2021
Q4
$676K Sell
249,350
-84,517
-25% -$312K ﹤0.01% 3772
2021
Q3
$1.49M Buy
333,867
+28,708
+9% +$138K ﹤0.01% 2968
2021
Q2
$1.77M Buy
305,159
+44,122
+17% +$259K ﹤0.01% 2792
2021
Q1
$1.83M Sell
261,037
-68,072
-21% -$456K ﹤0.01% 2559
2020
Q4
$1.58M Buy
329,109
+145,290
+79% +$735K ﹤0.01% 2243
2020
Q3
$1.07M Buy
+183,819
New +$1.1M ﹤0.01% 2132
2019
Q3
Sell
-28,174
Closed -$228K 5711
2019
Q2
$419K Sell
28,174
-15,733
-36% -$284K ﹤0.01% 2291
2019
Q1
$1.09M Sell
43,907
-378
-0.9% -$9.48K 0.01% 1348
2018
Q4
$795K Buy
44,285
+23,481
+113% +$480K 0.01% 1671
2018
Q3
$611K Sell
20,804
-5,300
-20% -$205K ﹤0.01% 2123
2018
Q2
$1.19M Sell
26,104
-4,678
-15% -$228K 0.01% 1553
2018
Q1
$1.63M Buy
30,782
+4,586
+18% +$268K 0.02% 1152
2017
Q4
$1.78M Sell
26,196
-79,204
-75% -$5.54M 0.01% 1268
2017
Q3
$8.69M Buy
105,400
+19,589
+23% +$1.55M 0.08% 306
2017
Q2
$8.03M Buy
85,811
+42,648
+99% +$2.61M 0.08% 282
2017
Q1
$2.75M Buy
43,163
+40,497
+1,519% +$2.46M 0.03% 668
2016
Q4
$118K Sell
2,666
-1,488
-36% -$52.4K ﹤0.01% 2747
2016
Q3
$150K Buy
+4,154
New +$89.1K ﹤0.01% 2671
2016
Q2
Sell
-18,816
Closed -$275K 5042
2016
Q1
$361K Sell
18,816
-11,581
-38% -$245K 0.01% 1931
2015
Q4
$1.06M Buy
30,397
+7,420
+32% +$479K 0.01% 1276
2015
Q3
$2.11M Buy
+22,977
New +$1.99M 0.03% 752
2014
Q3
Sell
-6,666
Closed -$278K 5562
2014
Q2
$276K Sell
6,666
-2,535
-28% -$131K ﹤0.01% 2123
2014
Q1
$637K Buy
9,201
+4,747
+107% +$349K 0.01% 1452
2013
Q4
$268K Buy
+4,454
New +$242K ﹤0.01% 2178

Other funds holding CLVS